Patient Scenario 3: Treating RR DTC With an Identified RET Fusion

Centering discussion on the final clinical scenario of RR DTC, Francis Worden, MD, highlights the management of a patient with an identified RET rearrangement.

Related Keywords

Francis Worden , ,Treatment Approaches ,Sequencing Strategies ,Differentiated Thyroid Cancer ,Thyroid Cancer ,Dtc Cancer ,Dtc ,Ret Fusions ,Ret Expression ,Lenvatinib ,Pembrolizumab ,Combination Therapy ,Selpercatinib ,Ret Inhibitor ,Cns ,Cns Disease ,